Evidence map›Paper›PMID 35927991›Full record

ArticleOxidative medicine and cellular longevity2022

Wumei Pill Ameliorates AOM/DSS-Induced Colitis-Associated Colon Cancer through Inhibition of Inflammation and Oxidative Stress by Regulating S-Adenosylhomocysteine Hydrolase- (AHCY-) Mediated Hedgehog Signaling in Mice.

Jue Wang, Kang Ding, Yuhang Wang, Tingdong Yan, Yun Xu, Zirong Deng, Weiling Lin, Libei Zhang, Weizhong Zhu, Rui Zhao and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jue WangSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0002-7083-3732
Kang DingNational Center of Colorectal Surgery, Jiangsu Integrate Colorectal Oncology Center, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China.ORCID https://orcid.org/0000-0002-1524-6332
Yuhang WangSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0001-9517-8570
Tingdong YanSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0002-5193-022X
Yun XuSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0002-3339-3344
Zirong DengSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0002-8737-9337
Weiling LinSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0001-9513-3196
Libei ZhangSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0001-8227-8126
Weizhong ZhuSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0002-8740-3210
Rui ZhaoSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0003-1543-0022
Yuhang ZhouSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0001-9877-7333
Zhaoguo LiuSchool of Pharmacy, Nantong University, 19 Qixiu Road, Nantong, Jiangsu Province 226001, China.ORCID https://orcid.org/0000-0001-6311-8338
Nantong University · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wumei Pill (WMP) is a traditional Chinese herbal formulation and widely used to treat digestive system diseases in clinical. S-Adenosylhomocysteine hydrolase (AHCY) can catalyze the hydrolysis of S-adenosylhomocysteine to adenosine and homocysteine in living organisms, and its abnormal expression is linked to the pathogenesis of many diseases including colorectal cancer (CRC). A previous study reported that WMP could prevent CRC in mice; however, the underlying mechanisms especially the roles of AHCY in WMP-induced anti-CRC remain largely unknown. Here, we investigated the regulatory roles and potential mechanisms of AHCY in WMP-induced anti-CRC. WMP notably alleviated the azoxymethane/dextran sulfate sodium- (AOM/DSS-) induced colitis-associated colon cancer (CAC) in mice. Besides, WMP inhibited the inflammation and oxidative stress in AOM/DSS-induced CAC mice. AHCY was high expression in clinical samples of colon cancer compared to the adjacent tissues. WMP inhibited the AHCY expression in AOM/DSS-induced CAC mice. An

Indexed as

ColitisColitis-Associated NeoplasmsColonic NeoplasmsColorectal NeoplasmsAdenosylhomocysteinaseAnimalsAzoxymethaneDextran SulfateDisease Models, AnimalDrugs, Chinese HerbalHedgehog ProteinsInflammationMiceMice, Inbred C57BLOxidative StressAdenosylhomocysteinaseAzoxymethaneDextran SulfateDrugs, Chinese HerbalHedgehog Proteinswumei

Identifiers

PMID35927991
PMCPMC9345734
OpenAlexW4288036962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.